Hydrogen Therapy Shows Promise for Child with Rare Brain Inflammation
Precision Assessment of Anti-NMDA Receptor Encephalitis: A Case Report on Integrating Clinical Course, Immunophenotyping, and Comprehensive Symptomatology in a Pediatric Patient With Adjunctive Hydrogen Therapy
Research hubs: Brain & Nervous System · Immune System
- Evidence type
- Case report or series · Human study
- Authors
- Shang-Chiang Lin, Jeng-Wei Lu, Ting-Chun Lin, Yueh-Feng Sung, Yi-Jung Ho, Fu-Min Wang, Shan-Wen Lui, Ting-Yu Hsieh, Kuang-Yih Wang, Feng-Cheng Liu
- Journal
- In Vivo
- Year
- 2025
- DOI
- 10.21873/invivo.13858
- Study Type
- Human
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- Taiwan
- Health Condition
- Anti-NMDA Receptor Encephalitis
- Body System
- Nervous System
TL;DR
This report details how a combination of careful monitoring, immune system testing, and hydrogen treatment helped in the recovery of a child with a rare brain inflammation.
Summary
The case report follows a child with anti-NMDA receptor encephalitis, an autoimmune disease causing brain inflammation, and tracks their recovery using detailed observations of their symptoms, immune system changes, and response to treatment. The study highlights the potential benefits of using hydrogen therapy—a novel treatment that involves inhaling hydrogen gas—as an additional treatment for this condition. The integrated approach of monitoring and treatment provided valuable insights into the disease's progression and the patient's improvement.
Abstract (excerpt)
Precision Assessment of Anti-NMDA Receptor Encephalitis: A Case Report on Integrating Clinical Course, Immunophenotyping, and Comprehensive Symptomatology in a Pediatric Patient With Adjunctive Hydrogen Therapy